NCT04585815 2026-01-09Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)PfizerPhase 1/2 Terminated34 enrolled 44 charts
NCT04458259 2025-08-28Study of PF-07265807 in Participants With Metastatic Solid Tumors.PfizerPhase 1 Terminated88 enrolled